Zegalogue
- Product NDC
- 80644-0012
- 11-digit product format
- 806440012
- Labeler code
- 80644
- Product ID
- 80644-0012_ed6f6c3a-a8ea-7c74-e053-2a95a90a232b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dasiglucagon
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Zealand Pharma US, Inc
- Application
- NDA214231
- Marketing category
- NDA
- Marketing start
- 2021-04-05
- Marketing end
- 0000-00-00
- Substance
- DASIGLUCAGON
- Active strength
- 1 mg/.6mL
- Pharmacologic classes
- Antihypoglycemic Agent [EPC], Glucagon Receptor Agonists [MoA], Increased Glycogenolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 80644-0012 | ZEGALOGUE (DASIGLUCAGON) INJECTION, SOLUTION [ZEALAND PHARMA US, INC] | 9 | Legacy NDC | 20250101_c6c32b47-c47c-4a7f-8d4d-23578f663217.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 80644-0012-1 | 80644001201 | 1 CONTAINER in 1 PACKAGE (80644-0012-1) > 1 SYRINGE, GLASS in 1 CONTAINER > .6 mL in 1 SYRINGE, GLASS | 1 container | 2021-04-05 | 0000-00-00 | No | No | Current |
| 80644-0012-2 | 80644001202 | 2 PACKAGE in 1 CARTON (80644-0012-2) > 1 CONTAINER in 1 PACKAGE > 1 SYRINGE, GLASS in 1 CONTAINER > .6 mL in 1 SYRINGE, GLASS | 2 package | 2021-04-05 | 0000-00-00 | No | No | Current |